Relationship Between Changes in Serum Levels of Keratin 18 and Changes in Liver Histology in Children and Adults With Nonalcoholic Fatty Liver Disease

被引:72
作者
Vuppalanchi, Raj [1 ]
Jain, Ajay K. [2 ]
Deppe, Ross [1 ]
Yates, Katherine [3 ]
Comerford, Megan [1 ]
Masuoka, Howard C. [1 ]
Neuschwander-Tetri, Brent A. [2 ]
Loomba, Rohit [4 ]
Brunt, Elizabeth M. [6 ]
Kleiner, David E. [7 ]
Molleston, Jean P. [1 ]
Schwimmer, Jeffrey B. [5 ,8 ]
Lavine, Joel E. [9 ]
Tonascia, James [3 ]
Chalasani, Naga [1 ]
机构
[1] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[2] St Louis Univ, St Louis, MO 63103 USA
[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[4] Univ Calif San Diego, Div Gastroenterol, San Diego, CA 92103 USA
[5] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA
[6] Washington Univ, Sch Med, St Louis, MO USA
[7] NCI, Pathol Lab, Bethesda, MD 20892 USA
[8] Rady Childrens Hosp, Dept Gastroenterol, San Diego, CA USA
[9] Columbia Univ, Dept Pediat, New York, NY 10027 USA
关键词
Serum K18; Noninvasive Biomarker; Nonalcoholic Steatohepatitis; PIVENS; TONIC; VITAMIN-E; CYTOKERATIN-18; FRAGMENTS; PLASMA CYTOKERATIN-18; HEPATIC STEATOSIS; STEATOHEPATITIS; PREVALENCE; APOPTOSIS; PIOGLITAZONE; EPIDEMIOLOGY; POPULATION;
D O I
10.1016/j.cgh.2014.05.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Cross-sectional studies have associated serum levels of the keratin 18 (K18) fragment with histologic features of liver in individuals with nonalcoholic fatty liver disease (NAFLD). We investigated the relationship between changes in serum levels of K18 and changes in liver histology in adults and children with NAFLD. METHODS: We measured levels of K18 in stored serum samples collected at baseline and various time points from 231 adults with nonalcoholic steatohepatitis and 152 children with NAFLD who participated in 2 separate prospective randomized clinical trials. Liver biopsy specimens collected at baseline and week 96 were reviewed centrally. RESULTS: There were greater decreases in serum levels of K18 in adults with histologic improvement at week 96 than in those without histologic improvement at week 16 (decrease, 193 +/- 293 vs 139 +/- 467 U/L; P < .001), week 48 (decrease, 232 +/- 360 vs 113 +/- 425 U/L; P < .001), or week 96 (decrease, 269 +/- 368 vs 97 +/- 400 U/L; P < .001). There were greater decreases in serum levels of K18 in children with histologic improvements than in those without histologic improvements at week 48 (decrease, 197 +/- 467 vs 47 +/- 350 U/L; P = .005) and week 96 (decrease, 206 +/- 432 vs 2 +/- 474 U/L; P < .001). However, reductions in serum levels of K18 were not better than reductions in levels of alanine aminotransferase in identifying adults with histologic improvement (area under the receiver operator characteristic [AUROC], 0.71; 95% confidence interval [CI], 0.63-0.80; vs AUROC, 0.68; 95% CI, 0.61-0.79; P = .34) or children (AUROC, 0.72; 95% CI, 0.63-0.81; vs AUROC, 0.79; 95% CI, 0.70-0.87; P = .42). CONCLUSIONS: Decreases in serum levels of K18 are associated strongly with improved liver histologies in adults or children with NAFLD. However, reductions in K18 do not perform better than those in alanine aminotransferase level in identifying histologic changes in NAFLD.
引用
收藏
页码:2121 / U416
页数:12
相关论文
共 34 条
  • [1] [Anonymous], 2010, M30 AP ELISA REF 100, P12
  • [2] The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
    Ascha, Mustafa S.
    Hanouneh, Ibrahim A.
    Lopez, Rocio
    Tamimi, Tarek Abu-Rajab
    Feldstein, Ariel F.
    Zein, Nizar N.
    [J]. HEPATOLOGY, 2010, 51 (06) : 1972 - 1978
  • [3] Epidemiology of Non-Alcoholic Fatty Liver Disease
    Bellentani, Stefano
    Scaglioni, Federica
    Marino, Mariano
    Bedogni, Giorgio
    [J]. DIGESTIVE DISEASES, 2010, 28 (01) : 155 - 161
  • [4] Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
    Browning, JD
    Szczepaniak, LS
    Dobbins, R
    Nuremberg, P
    Horton, JD
    Cohen, JC
    Grundy, SM
    Hobbs, HH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1387 - 1395
  • [5] Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression
    Canbay, A
    Feldstein, AE
    Higuchi, H
    Werneburg, N
    Grambihler, A
    Bronk, SF
    Gores, GJ
    [J]. HEPATOLOGY, 2003, 38 (05) : 1188 - 1198
  • [6] Apoptosis: The nexus of liver injury and fibrosis
    Canbay, A
    Friedman, S
    Gores, GJ
    [J]. HEPATOLOGY, 2004, 39 (02) : 273 - 278
  • [7] The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Diehl, Anna Mae
    Brunt, Elizabeth M.
    Cusi, Kenneth
    Charlton, Michael
    Sanyal, Arun J.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (06) : 811 - 826
  • [8] Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
    Chalasani, Naga P.
    Sanyal, Arun J.
    Kowdley, Kris V.
    Robuck, Patricia R.
    Hoofnagle, Jay
    Kleiner, David E.
    Uenalp, Aynur
    Tonascia, James
    [J]. CONTEMPORARY CLINICAL TRIALS, 2009, 30 (01) : 88 - 96
  • [9] Chen J, 2013, HEPATOL RES
  • [10] Cui JS, 1999, STAT MED, V18, P527, DOI 10.1002/(SICI)1097-0258(19990315)18:5<527::AID-SIM54>3.0.CO